Robert M. Prins - Concepedia

Author

Robert M. Prins

University of California, Los Angeles ORCID

Also Known As

Cees van der Lans, Gail Prins, Hideho Okada, L. Liau, M Gráf, M. GRAF, M. Graf, M. ROBERT, Martin R. Graf, Robert M. Prins, William T, Michael K.B. Ford

482

Publications

16.4K

Citations

H-Index

103

Concepts

All Affiliations

University of California, Los Angeles UCLA Jonsson Comprehensive Cancer Center Parker Institute for Cancer Immunotherapy University of California, San Francisco UCLA Medical Center

About

Robert M. Prins is an author at University of California, Los Angeles specializing in medicine, glioma, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	30	9.1K
2	Engineering	5	5	141
3	Education	2	2	47
4	Natural Sciences	1	1	236
5	Allergy	1	1	120

Robert M. Prins

Publications

14.5K

Citations

H-Index

Page 1

	Year	Citations
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Lenny Dang, David W. White, Bryson D. Bennett, Nature Tumor BiologyCancer-associated Idh1 MutationsOncogenic AgentPathologyCancer Genetics	2009	4K
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla, Nature Medicine Neuro-oncologyNeoadjuvant Anti-pd-1 ImmunotherapyTumor ImmunologyCancer ImmunosurveillanceGlioma	2019	1.3K
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Lenny Dang, David W. White, Bryson D. Bennett, Nature Tumor BiologyCancer-associated Idh1 MutationsOncogenic AgentPathologyCancer Genetics	2010	585
Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment Linda M. Liau, Robert M. Prins, Sylvia M. Kiertscher, Clinical Cancer Research	2005	540
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma Linda M. Liau, Keyoumars Ashkan, David D. Tran, Journal of Translational Medicine	2018	528
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. John S. Yu, Christopher J. Wheeler, Paul M. Zeltzer, PubMed ImmunologyPathologyImmunotherapyGliomaNeuro-oncology	2001	514
Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy Robert M. Prins, Horacio Soto, Vera Konkankit, Clinical Cancer Research	2010	454
An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway Deliang Guo, Felicia Reinitz, Mary Youssef, Cancer Discovery Chemoprevention StrategyCell DeathGbm Cell LinesCancer BiologyGlioma	2011	435
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma Linda M. Liau, Keyoumars Ashkan, Steven Brem, JAMA Oncology	2022	356
EGFR Signaling Through an Akt-SREBP-1–Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy Deliang Guo, Robert M. Prins, Julie Dang, Science Signaling	2009	335

Page 1